Breast cancer patients may have better option to reduce oestrogen levels
11 Mar 2009
Breast cancer patients may have better option to reduce oestrogen levels
Use of written forms doubles breast cancer detection rate
Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy
Poor prognosis on small, HER2 positive tumours
Azacitidine for Myelodysplastic Syndrome
Effects of Myelodysplastic Syndrome
How azacitidine works
Myelodysplastic Syndromes and Acute Myeloid Leukaemia
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
Winners from the UICC's Cancer Film Festival
Complex Events and Emergence in Cancer Systems
Clinical Requirements Regarding In Silico Oncology